Location History:
- Machida, JP (2010 - 2014)
- Gosen, JP (2019)
Company Filing History:
Years Active: 2010-2019
Title: Noriyuki Izutani: Innovator in Influenza Virus Research
Introduction
Noriyuki Izutani is a notable inventor based in Machida, Japan. He has made significant contributions to the field of influenza virus research, holding a total of 3 patents. His work focuses on innovative methods for measuring and producing influenza virus antigens, which are crucial for vaccine development and disease management.
Latest Patents
Izutani's latest patents include a novel method for measuring hemagglutinin from the influenza virus. This method allows for the construction of an assay system in a shorter period than traditional sandwich immunoassay methods that utilize two types of anti-hemagglutinin antibodies. The method effectively sandwiches the hemagglutinin between a lectin that binds specifically to it and an anti-hemagglutinin antibody, facilitating accurate measurement.
Another significant patent is his method for producing purified influenza virus antigen. This invention aims to efficiently remove impurities, such as host proteins, from an influenza virus culture liquid through a simple operation. The process involves treating a sample with a surfactant, contacting it with hydroxyapatite, and recovering a hydroxyapatite-non-adsorbed fraction, thereby allowing for effective separation and purification of the antigen.
Career Highlights
Throughout his career, Izutani has worked with prominent companies in the biotechnology sector, including Denka Seiken Co., Ltd. and Denki Kagaku Kogyo Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in developing innovative solutions for influenza virus research.
Collaborations
Izutani has collaborated with notable colleagues such as Koichi Takahashi and Hitoshi Ikeya. These partnerships have further enhanced his research capabilities and have led to advancements in the field of virology.
Conclusion
Noriyuki Izutani's contributions to influenza virus research through his innovative patents demonstrate his commitment to advancing medical science. His work not only aids in the understanding of influenza but also plays a vital role in public health initiatives.